TransMed7 announced that it has entered a strategic partnership with Peridot Corp. went into effect on Aug. 21. The two privately-held companies design and develop medical device technologies and offer end-to-end precision manufacturing and clean room assembly services.
“This new strategic partnership with Peridot enables TransMed7 to launch new products such as our Concorde and Martinet technologies directly into the market immediately following FDA clearance,” said Eugene H. Vetter, TransMed7’s co-founder and CEO. “Peridot was our contract manufacturer for our SpeedBird platform needle sets and we are excited to be expanding our relationship with Peridot for timed product commercial release in significant quantities for strategic market penetration.”
TransMed7 creates technology that services a number of medical fields including breast, abdominal, thoracic, head and neck, urologic, endoscopic, robotic, laparoscopic and therapeutic endovascular.
“The Peridot team is truly gratified and very excited to have been chosen as the strategic partner by TransMed7 in this endeavor. Peridot’s deeply diverse technical capabilities in the field of minimally invasive devices could with our demonstrated agility will certainly enable TransMed7 to meet and exceed their clinical goals,” said Patrick Pickerell, Peridot’s co-founder and president. “This is an incredible opportunity for Peridot to be at the forefront of developing technologies that are sure to lead to better patient outcomes.”
|
Speak Your Mind